ARTICLE | Company News
Argonex and Wyeth-Lederle in Chlamydia deal
February 3, 2000 8:00 AM UTC
Argonex (Charlottesville, Va.) and Wyeth-Lederle Vaccines will indentify antigens associated with Chlamydia pneumoniae for the development of vaccines. Argonex will identify peptides expressed on Chla...